ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd赞助的临床试验
总计1455个结果
-
Staidson (Beijing) Biopharmaceuticals Co., Ltd招聘中
-
Suzhou Zelgen Biopharmaceuticals Co.,Ltd招聘中
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Jiangsu Alphamab Biopharmaceuticals Co., Ltd尚未招聘
-
Suzhou Zelgen Biopharmaceuticals Co.,Ltd尚未招聘
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.尚未招聘活动性中度至重度 Graves 眼眶病
-
Chengdu Easton Biopharmaceuticals Co,Ltd招聘中
-
Suzhou Zelgen Biopharmaceuticals Co.,Ltd终止
-
Suzhou Zelgen Biopharmaceuticals Co.,Ltd完全的
-
Suzhou Zelgen Biopharmaceuticals Co.,Ltd完全的
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.邀请报名
-
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.完全的
-
FutureGen Biopharmaceutical (Beijing) Co., Ltd招聘中局部晚期不可切除或转移性胃癌 | 局部晚期不可切除或转移性胃食管结合部 (GEJ) 腺癌中国